Menu Close

Trending

Data backs AZ’s Wilson disease drug, but with a question mark
Fujifilm acquires AI tech to improve fertility treatment
Sarepta shares yo-yo as FDA places hold on Duchenne trial
New countries stockpile antiviral TPOXX as monkeypox outbreak continues
Biogen and Happify partner on digital support for MS patients

Seres Therapeutics

Bacteria

News/ News/ Sales and Marketing

Nestle gets closer to Seres, pledging $525m for microbiome C. diff drug

, , , , , 0 Comment

Swiss food giant Nestle has firmed up its five-year-old alliance with US microbiome specialist Seres, paying $175 million

X
Nestle gets closer to Seres, pledging $525m for microbiome C. diff drug
https://pharmaphorum.com/news/nestle-gets-closer-to-seres-pledging-525m-for-microbiome-c-diff-drug/
astrazeneca-sign

News/ News/ Oncology

AZ joins with Seres to research role of gut microbiome in cancer

, , , , 0 Comment

AstraZeneca has announced an immuno-oncology collaboration with US biotech Seres Therapeutics, which will focus on increasing understanding of

X
AZ joins with Seres to research role of gut microbiome in cancer
https://pharmaphorum.com/news/az-joins-with-seres-to-research-role-of-gut-microbiome-in-cancer/

Login

CONTINUE TO SITE >
X
Close in 10 seconds